Julie Smith
Vermogen: 2 M $ op 31-10-2026
Vermogen: 2 M $ op 31-10-2026
Julie Anne Smith is Chief Executive Officer & Director at Juvena Therapeutics, Inc. since 2026.
Independent Director at Exelixis, Inc. since 2016.
Independent Director at Stoke Therapeutics, Inc. since 2020.
Formerly President, Chief Executive Officer & Director at Horizon Pharmaceutical LLC from 2015 to 2016.
President & Chief Executive Officer at Raptor Pharmaceuticals, Inc. from 2015 to 2016.
President, Chief Executive Officer & Director at Nuredis, Inc. from 2017 to 2018.
Chief Executive Officer & Director at Nuvig Therapeutics, Inc. Former President, Chief Executive Officer & Director at ESCAPE Bio, Inc. from 2018 to 2022.
Director-Channel Strategy & Design at Bristol Myers Squibb Co. Director-Health & Emerging Companies Sections at Biotechnology Innovation Organization.
Independent Director at Astellas Gene Therapies, Inc. from 2016 to 2020.
Vice President-Commercial at Jazz Pharmaceuticals, Inc. from 2006 to 2008.
Vice President-Global Marketing at Genzyme General from 2001 to 2005.
Head-Operations & Business Development at Novazyme Pharmaceuticals, Inc. from 2000 to 2001.
Chief Commercial Officer & Vice President at Enobia Pharma, Inc. from 2008 to 2012.
Education includes undergraduate degree from Cornell University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
EXELIXIS, INC. 0,01% | 27-05-2026 | 28.957 ( 0,01% ) | 2 M $ | 31-10-2026 |
| 03-06-2026 | 0 ( -.--% ) | - $ | 31-10-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| EXELIXIS, INC. | Directeur/Bestuurslid | 22-09-2016 |
| STOKE THERAPEUTICS, INC. | Directeur/Bestuurslid | 04-06-2020 |
Juvena Therapeutics, Inc.
Juvena Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics treatment and platform for myopathies and metabolic diseases | Algemeen Directeur | 17-08-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
ESCAPE Bio, Inc.
ESCAPE Bio, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics against genetic targets for neurodegenerative disease | Algemeen Directeur | 01-08-2022 |
| AUDENTES THERAPEUTICS, INC. | Directeur/Bestuurslid | 15-01-2020 |
Nuredis, Inc.
Nuredis, Inc. BiotechnologyHealth Technology Develops treatments for neurodegenerative and neuromuscular diseases | Algemeen Directeur | 01-06-2018 |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and markets life-altering therapeutics | Algemeen Directeur | 01-10-2016 |
Enobia Pharma, Inc.
Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for bone disorders | Corporate Officer/Principal | 01-05-2012 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 16 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Exelixis, Inc.
Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Genzyme General
Genzyme General Medical SpecialtiesHealth Technology Develops and markets specialty therapeutic, surgical, and diagnostic products | Health Technology |
Novazyme Pharmaceuticals, Inc.
Novazyme Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops methods for modifying recombinantly produced enzymes | Commercial Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enobia Pharma, Inc.
Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for bone disorders | Health Technology |
Horizon Pharmaceutical LLC
Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of life-altering therapeutics that treat debilitating and often fatal diseases | Health Technology |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and markets life-altering therapeutics | Health Technology |
Astellas Gene Therapies, Inc.
Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
ESCAPE Bio, Inc.
ESCAPE Bio, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics against genetic targets for neurodegenerative disease | Health Technology |
Nuredis, Inc.
Nuredis, Inc. BiotechnologyHealth Technology Develops treatments for neurodegenerative and neuromuscular diseases | Health Technology |
Juvena Therapeutics, Inc.
Juvena Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics treatment and platform for myopathies and metabolic diseases | Health Technology |
Nuvig Therapeutics, Inc.
Nuvig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops translating novel therapeutics medicine for autoimmune diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau